首页> 外文会议>Asian Symposium on biomedical materials >All-trans Retinoic Acid (atRA) Release from atRA-Loaded Folate-Poly(ethylene glycol)/Polyethylenimine Nanoparticles for Folate-Mediated Tumor Targeting
【24h】

All-trans Retinoic Acid (atRA) Release from atRA-Loaded Folate-Poly(ethylene glycol)/Polyethylenimine Nanoparticles for Folate-Mediated Tumor Targeting

机译:用于叶酸介导的肿瘤靶向的ATRA负载叶酸叶酸叶酸(乙二醇)/聚乙烯亚胺纳米颗粒中的全反式视黄酸(ATRA)释放

获取原文

摘要

To improve the specific accumulation in tumor sites and aqueous solubility of atRA, the core-shell type of folate-PEG-g-PEI/atRA nanoparticles were prepared by complexation between cationic PEI segments in the copolymers and anionic charged atRA, and then characterized by ~1H-NMR, ELS, XRD, and TEM. In vitro atRA release from the nanoparticles was investigated as a function of drug content in sink condition. Cytotocicity of atRA against HepG2, KB cell lines were also evaluated by MTT assay. The lower the drug content, the faster atRA release. atRA incorporated in folate-PEG-g-PEI/atRA nanoparticles showed much higher cytotoxic effect compared with atRA itself.
机译:为了改善肿瘤部位和ATRA的含水溶解度的特定积累,通过阳离子PEI段之间的共聚物和阴离子带电ATRA的阳离子PEI区段之间的络合来制备叶酸-PEG-G-PEI / ATRA纳米粒子的核壳类型,然后表征〜1H-NMR,ELS,XRD和TEM。以纳米颗粒在体外ATRA释放作为下沉条件下药物含量的函数。通过MTT测定还评估ATRA对HepG2,KB细胞系的细胞织物。药物含量越低,ATRA释放越快。与ATRA本身相比,ATRA掺入叶酸 - PEG-PEI / ATRA纳米粒子上显示出更高的细胞毒性作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号